C39H36F3N7O7S — CID 156507311
2-[4-[3-(2,6-dioxopiperidin-3-yl)-1-methylindazol-6-yl]-3,3-difluoropiperidin-1-yl]-N-[5-fluoro-7-phenylmethoxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]acetamide (PubChem CID 156507311) has the molecular formula C39H36F3N7O7S and a molecular weight of 803.82 g/mol. Its IUPAC name is 2-[4-[3-(2,6-dioxopiperidin-3-yl)-1-methylindazol-6-yl]-3,3-difluoropiperidin-1-yl]-N-[5-fluoro-7-phenylmethoxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]acetamide.
| Compound Name | 2-[4-[3-(2,6-dioxopiperidin-3-yl)-1-methylindazol-6-yl]-3,3-difluoropiperidin-1-yl]-N-[5-fluoro-7-phenylmethoxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]acetamide |
|---|---|
| PubChem CID | 156507311 |
| Molecular Formula | C39H36F3N7O7S |
| Molecular Weight | 803.82 g/mol |
| Exact Mass | 803.23 |
| IUPAC Name | 2-[4-[3-(2,6-dioxopiperidin-3-yl)-1-methylindazol-6-yl]-3,3-difluoropiperidin-1-yl]-N-[5-fluoro-7-phenylmethoxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]acetamide |
| SMILES | Cn1nc(C2CCC(=O)NC2=O)c2ccc(C3CCN(CC(=O)Nc4ccc5c(F)c(N6CC(=O)NS6(=O)=O)c(OCc6ccccc6)cc5c4)CC3(F)F)cc21 |
| InChI | InChI=1S/C39H36F3N7O7S/c1-47-30-16-23(7-9-27(30)36(45-47)28-11-12-32(50)44-38(28)53)29-13-14-48(21-39(29,41)42)18-33(51)43-25-8-10-26-24(15-25)17-31(56-20-22-5-3-2-4-6-22)37(35(26)40)49-19-34(52)46-57(49,54)55/h2-10,15-17,28-29H,11-14,18-21H2,1H3,(H,43,51)(H,46,52)(H,44,50,53) |
| InChIKey | ITRYSLSKESZOLU-UHFFFAOYSA-N |
| XLogP | 4.21 |
| TPSA | 172.04 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 57 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 803.82 |
| LogP ≤ 5 | 4.21 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 10 |
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|